Page last updated: 2024-11-06

n-nitrosoguvacoline

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

N-nitrosoguvacoline: formed by nitrosation of arecoline [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID62103
CHEMBL ID165231
CHEBI ID82512
MeSH IDM0111512

Synonyms (23)

Synonym
n-nitrosoguvacoline
55557-02-3
methyl 1-nitroso-1,2,5,6-tetrahydropyridine-3-carboxylate
1-nitroso-1,2,5,6-tetrahydronicotinic acid methyl ester
ccris 3050
brn 0391077
nicotinic acid, 1,2,5,6-tetrahydro-1-nitroso-, methyl ester
nitrosoguvacoline
3-pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-nitroso-, methyl ester
methyl 1-nitroso-3,6-dihydro-2h-pyridine-5-carboxylate
n-nitroso guvacoline
chebi:82512 ,
CHEMBL165231
AKOS006277935
C19482
unii-dt8d8h2tx8
dt8d8h2tx8 ,
FT-0672959
NXEUEKXJAAVKCT-UHFFFAOYSA-N
methyl 1-nitroso-1,2,5,6-tetrahydro-3-pyridinecarboxylate #
DTXSID6021038
Q27156024
nitrosoguvacoline, n-
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
citraconoyl group
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID226733Carcinogenic potency modelled in silico, (- = non-carcinogen)1982Journal of medicinal chemistry, Jul, Volume: 25, Issue:7
Computer-assisted studies of structure-activity relationships of N-nitroso compounds using pattern recognition.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (6)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (83.33)18.7374
1990's1 (16.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 12.35

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index12.35 (24.57)
Research Supply Index1.95 (2.92)
Research Growth Index4.29 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (12.35)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other6 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]